TOKYO - A team of University of Tokyo researchers said Thursday it will begin a clinical study later this month on a vaccine for the Ebola virus, a first in Japan, with the vaccine developed using an artificially produced detoxified virus.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
